Trials / Completed
CompletedNCT04301752
Cognitive Impairment and Neuropsychiatric Manifestations of Neurobrucellosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 82 (actual)
- Sponsor
- Mansoura University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Brucellosis is a common zoonotic infection in many parts of the world including the Mediterranean and Middle Eastern countries. Neurobrucellosis may develop at any stage of disease and may have widely variable manifestations, including encephalitis, meningoencephalitis, radiculitis, myelitis, peripheral and cranial neuropathies, subarachnoid hemorrhage, and psychiatric manifestations.
Detailed description
Brucellosis is a common zoonotic infection in many parts of the world including the Mediterranean and Middle Eastern countries. Neurobrucellosis may develop at any stage of disease and may have widely variable manifestations, including encephalitis, meningoencephalitis, radiculitis, myelitis, peripheral and cranial neuropathies, subarachnoid hemorrhage, and psychiatric manifestations. The aimed is to shed light to the obscure areas of diagnosis in neurobrucellosis and have detailed general and neurologic features
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | MoCA | Cognitive function was assessed by using MoCA score. Cognitive impairment was considered present when MoCA scores were \<26. Maximum score is 30. |
Timeline
- Start date
- 2019-02-01
- Primary completion
- 2020-01-01
- Completion
- 2020-03-01
- First posted
- 2020-03-10
- Last updated
- 2020-03-18
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04301752. Inclusion in this directory is not an endorsement.